Genomic structure and cloning of two transcript isoforms of human Sp8 by Milona, Maria-athina et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Genomics
Open Access Research article
Genomic structure and cloning of two transcript isoforms of human 
Sp8
Maria-athina Milona1, Julie E Gough2 and Alasdair J Edgar*3
Address: 1Department of Cell Biology and Genetics, Faculty of Medicine, Erasmus Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, 
The Netherlands, 2Manchester Materials Science Centre, University of Manchester and UMIST, Grosvenor St., Manchester, M1 7HS, United 
Kingdom and 3Department of Craniofacial Development, GKT Dental Institute, King's College, Guy's Hospital, London, SE1 9RT, United 
Kingdom
Email: Maria-athina Milona - m.mylona@erasmusmc.nl; Julie E Gough - j.gough@umist.ac.uk; Alasdair J Edgar* - alasdair.edgar@kcl.ac.uk
* Corresponding author    
Abstract
Background: The Specificity proteins (Sp) are a family of transcription factors that have three
highly conserved zinc-fingers located towards the carboxy-terminal that bind GC-boxes and assist
in the initiation of gene transcription. Human Sp1-7 genes have been characterized. Recently, the
phenotype of Sp8 null mice has been described, being tailless and having severe truncation of both
fore and hind limbs. They also have malformed brains with defective closure of the anterior and
posterior neuropore during brain development.
Results: The human Sp8 gene is a three-exon gene that maps to 7p21.3, close to the related Sp4
gene. From an osteosarcoma cell line we cloned two transcript variants that use two different first
exons and have a common second exon. One clone encodes a 508-residue protein, Sp8L (isoform
1) and the other a shorter 490-residue protein, Sp8S (isoform 2). These two isoforms are
conserved being found also in mice and zebrafish. Analysis of the Sp8L protein sequence reveals an
amino-terminal hydrophobic Sp-motif that is disrupted in Sp8S, a buttonhead box and three C2H2
zinc-fingers. Sp8 mRNA expression was detected in a wide range of tissues at a low level, with the
highest levels being found in brain. Treatment of the murine pluripotent cell line C3H10T1/2 with
100 ng/mL BMP-2 induced Sp8 mRNA after 24 hours.
Conclusions: There is conservation of the two Sp8 protein isoforms between primates, rodents
and fish, suggesting that the isoforms have differing roles in gene regulation. Sp8 may play a role in
chondrogenic/osteoblastic differentiation in addition to its role in brain and limb development.
Background
We are interested in understanding how Specificity pro-
teins (Sp) govern extracellular matrix deposition during
bone formation. The Sp proteins are a family of transcrip-
tion factors with three zinc-fingers that bind GC-boxes
and assist the further binding of the multiprotein complex
TFIID promoting the initiation of gene transcription [1-4].
GC-boxes have the consensus sequence GGGCGGG. Sp1
and Sp3 are associated with chondrocytic differentiation
by regulating the alpha1(II) procollagen gene (COL2A1),
a chondrocytic marker. Sp1 has been shown to be an acti-
vator and Sp3 a repressor of COL2A1 transcription [5].
Despite the ubiquitous expression of Sp3, Sp3 null mice
suffer from specific skeletal defects associated with a delay
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in osteoblast differentiation, having reduced ossification
and impaired bone formation and show a decrease in the
expression of osteocalcin, an osteoblast specific gene [6].
Sp7, also known as Osterix, is required for osteoblast dif-
ferentiation since in Sp7 null mice bone formation does
not occur [7]. Previously, we cloned two isoforms of
human Sp7 that are generated from distinct promoters
upstream of exon 1a and exon 1b [8]. We identified
another human Sp gene that is closely related to Sp7 and
named it Sp8. Recently, Sp8 null mice have been
described [9,10]. Note that the mouse mBtd gene [10] is
Sp8 and not a specific homologue of the Drosophila gene
buttonhead (Btd) [11]. However, Btd is a member of the
Sp family [12]. Sp8 null mice have a well-defined pheno-
type, having severe truncation of all limbs and no tail.
Their malformed brains have defective closure of the ante-
rior and posterior neuropores that leads to exencephaly
and spina bifida. Sp8 is required for proper maintenance
and maturation of the apical ectodermal ridge, a signal-
ling centre, which forms at the limb bud apex and governs
the outgrowth of the limb during development. Here we
describe the sequence of two isoforms of human Sp8.
Results
In our search for additional Sp transcription factors, we
performed a TblastN search of the human genome with
the sequence of Sp7 [8]. The most closely related
sequences were found on genomic DNA BAC clones CTA-
324D18 and CTB-86D3 that were in the draft stage (Gen-
Bank accession Nos. AC005251 and AC005060 Genome
Sequencing Center, Washington University, USA). This
new gene was named Sp8 since it is closely related to Sp7.
Human Sp8 cDNAs
Utilising the sequences of the two BAC clones, PCR prim-
ers were designed to amplify probable cDNAs. Two differ-
ent cDNA clones were obtained by RT-PCR from the
human MG-63 osteosarcoma cell line and sequenced (Fig.
1). Successful amplification and sequencing required
methods designed to overcome problematic GC-rich
regions. These transcript variants differed at their 5' ter-
mini. Clone 1 comprises exon 1a and 2, and together they
encode the long protein isoform of Sp8 (Sp8L)(Fig.
1)(GenBank accession No. AY167047). Clone 2 com-
prises the untranslated exon 1b and exon 2. Exon 1b con-
tains an in-frame stop codon and no initiation
methionine codon. Together they encode the short pro-
tein isoform (Sp8S)(Fig. 1)(GenBank accession No.
AY167048). The first ATG codon of Sp8L is in excellent
sequence consensus for an initiation methionine having a
guanosine residue at positions -3 and +4, and that of Sp8S
is in good sequence consensus having a guanosine at -3
[13]. The ORF is GC rich (70%). Another Sp8 cDNA clone
was isolated from the osteoblasts of a patient with oste-
oporosis. This has a glycine-165 deletion; having lost one
of the five sequential GGC codons (nucleotides 569–583)
(Fig. 1).
Human Sp8 gene
After the completion of the human genome the location
and structure of the human Sp8 gene was identified by
mapping the sequences of Sp8L and Sp8S cDNA clones.
The human Sp8 gene maps to 7p21.3 between the multi-
drug resistance protein (P-glycoprotein) and ribosomal
protein L23 genes and is separated by 0.65 Mbp from the
related Sp4 gene by seven genes encoding two ribosomal
proteins, four putative genes of unknown function and a
gene similar to argininosuccinate synthetase. The Sp8 and
Sp4 genes are linked to the homeobox gene cluster HOX
A, which is 5.6 Mbp away. The human Sp8 gene spans 4.6
kb and has three exons (Fig. 2). Exons 1a and 1b encode
different transcript variants that are likely to be initiated
from distinct promoters. The first two exons are separated
by a 733 bp intron 1a, followed by a shorter, 152 bp
intron 1b. All splice donor/acceptor sites contained con-
sensus GT/AG dinucleotides. The gene possesses a CpG
island upstream of exon 1a (438 bp, 63% GC). Computer
analysis of the immediate human Sp8 promoter preced-
ing exon 1a contains a number of RNA polymerase II pro-
moter elements including a TATA-box, CCAAT-box and
two GC-boxes that are conserved in rodents and fish.
Comparison of the human Sp8 protein with those of other 
species
The ORF of Sp8L clone 1 encodes a 508-residue protein
with a 50,500 Da molecular mass and an isoelectric point
9.02. The first ATG codon of clone 2 corresponds to the
second ATG of clone 1, thereby omitting the first 18 resi-
dues of the ORF, encoding a 490-residue protein with a
48,674 Da molecular mass and an isoelectric point 9.10.
The human Sp8 protein belongs to the Sp/Krüppel like
factor (KLF) family of proteins that are characterised by
three Cys2-His2 zinc-fingers [14]. The zinc-fingers are
located towards the COOH terminus and are involved in
binding DNA in a sequence specific manner. However,
the Sp proteins are distinguished from the KLF family by
an amino-terminal hydrophobic domain called the Sp-
motif with the consensus sequence PLALLA and a button-
head box (BTD) with the consensus sequence CxCP(N/
Y)C prior to the zinc finger domain.
Database searches identified complete Sp8 genes and pro-
tein sequences from other vertebrate species. The chim-
panzee gene is located on chromosome 7 (clone RP43-
37F3); the mouse gene at 12F2 (BAC clone RP23-
161L22); the rat gene at 6q33 on BAC clone CH230-1K24
and the zebrafish within BAC clone CH211-180P9. A
comparison of the protein sequences shows that Sp8 is
well conserved through vertebrate evolution (Fig. 3). TheBMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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human and chimpanzee proteins are very similar with
one conservative substitution and an additional glycine
residue. The mouse Sp8 protein [9,10,15] has 97% iden-
tity and the zebrafish 79% identity to human Sp8. An
amphibian Sp8 EST from Xenopus laevis was identified by
our database search (accession No. BI313193). The mam-
malian Sp8 proteins differ from that of the zebrafish by
the insertion of two poly-alanine and a poly-glycine
region in the amino-half of the protein.
Database searches also showed that homologues of the
vertebrate Sp8 genes are found in insects, but not in nem-
atodes, yeasts and higher plants (Fig. 4). The fruit fly, Dro-
sophila melanogaster, D-Sp1 gene is a homologue of Sp8
Human Sp8 cDNA sequences encompassing the ORF and translation Figure 1
Human Sp8 cDNA sequences encompassing the ORF and translation. (A) Sequence encoding exon 1a encoding the start of 
Sp8L protein isoform. (B) Sequence encoding the untranslated exon 1b encoding the Sp8S protein isoform. (C) Sequence 
encoding the common exon 2. The atg/methionine start codon for the long protein isoform is shown in bold and coloured red 
and that of the short protein isoform coloured pink. The ORF stop codon, tga, is shown in bold and coloured red and is indi-
cated by a red asterisk. An in-frame stop codon, tag, in the 5'UTR of exon 1b is shown in bold and coloured red. The exon/
exon boundaries were determined by comparison with the sequence of genomic DNA clone CTA-324D18. The nucleotides 
underlined and shown in bold type indicate the location of the exon/exon boundaries. The loss of a GGC (glycine) codon 
found in an additional Sp8 clone is shown in green and bolded.
(A) Exon 1a 
-88   attgtattgcacacctctaaaaaaaacactgcctctgatttatcaatataaaaaagatcctctgagaggaggagggcacttttgtgtg
  1 atggcaacttcacttctaggg
    M  A  T  S  L  L  G   
(B) Exon 1b 
-97 gcgtggtgcttgctcccgaatcagacgccggcagccaaacttgtcccctcctgtagagtaggaagcggccgggcgccggggctgttgggg 
    gtgccag
(C) Exon 2 
                         gaagaaccgaggttgggatcgactcctctggccatgcttgccgctacctgtaataagataggcagcccc 
                         E  E  P  R  L  G  S  T  P  L  A  M  L  A  A  T  C  N  K  I  G  S  P 
 91 agcccgtctccctcctccctctcggacagctcttcttccttcggcaaaggcttccacccctggaaacgctcctcgtcctcttcttccgcc 
    S  P  S  P  S  S  L  S  D  S  S  S  S  F  G  K  G  F  H  P  W  K  R  S  S  S  S  S  S  A 
181 agctgcaacgtagtgggttccagtctctcaagcttcggcgtgtccggggcctccaggaacggcggctcgtcctcggcggctgcggcggcc 
    S  C  N  V  V  G  S  S  L  S  S  F  G  V  S  G  A  S  R  N  G  G  S  S  S  A  A  A  A  A 
271 gcggcagcagccgcggctgccgcggccctggtgtccgactcgttcagctgcggcggctcgcctggctccagcgccttctccctcacctcc 
    A  A  A  A  A  A  A  A  A  L  V  S  D  S  F  S  C  G  G  S  P  G  S  S  A  F  S  L  T  S 
361 agcagcgccgcagccgccgccgccgccgccgcagccgccgcctccagctcgcccttcgccaacgactactctgttttccaggcccccgga 
    S  S  A  A  A  A  A  A  A  A  A  A  A  A  S  S  S  P  F  A  N  D  Y  S  V  F  Q  A  P  G 
451 gtttccgggggcagcggcggcggcggcgggggcggcggcggcggctcctccgcgcactcgcaggacggctcccaccagccggtgttcatc 
    V  S  G  G  S  G  G  G  G  G  G  G  G  G  G  S  S  A  H  S  Q  D  G  S  H  Q  P  V  F  I 
541 tccaaggtgcacacctctgtggacgggctgcagggcatctacccgcgggtgggcatggcgcacccgtacgagtcgtggtttaagccctcg 
    S  K  V  H  T  S  V  D  G  L  Q  G  I  Y  P  R  V  G  M  A  H  P  Y  E  S  W  F  K  P  S 
631 cacccgggcctgggtgctgcgggcgaggtgggctcggccggcgcctccagctggtgggacgtgggggccggctggatcgacgtgcagaac 
    H  P  G  L  G  A  A  G  E  V  G  S  A  G  A  S  S  W  W  D  V  G  A  G  W  I  D  V  Q  N 
721 ccgaacagcgcggctgcgctgcccggctcgctgcaccctgccgccggggggctccaaacctcgctgcactcgccgctcggaggctacaac 
    P  N  S  A  A  A  L  P  G  S  L  H  P  A  A  G  G  L  Q  T  S  L  H  S  P  L  G  G  Y  N 
811 tcggattactcgggcctgagtcactcggccttcagcagcggcgcctcctcgcacctgctcagccccgccgggcagcacctcatggacggc 
    S  D  Y  S  G  L  S  H  S  A  F  S  S  G  A  S  S  H  L  L  S  P  A  G  Q  H  L  M  D  G 
901 ttcaagccagtgctacccggctcctacccggactcggccccgtcgccgctggccggcgcggggggctccatgttgagcgctgggccttcg 
    F  K  P  V  L  P  G  S  Y  P  D  S  A  P  S  P  L  A  G  A  G  G  S  M  L  S  A  G  P  S 
991 gcgccgctggggggctccccgcgctcctcagctcgccgctactccggccgcgccacctgcgactgccccaactgccaggaggcagagcgg 
    A  P  L  G  G  S  P  R  S  S  A  R  R  Y  S  G  R  A  T  C  D  C  P  N  C  Q  E  A  E  R 
1081 ctgggccctgccggggcgagcttgcggcgcaagggcctgcacagctgccacatcccgggctgcggcaaggtgtacggcaagacttcgcac 
    L  G  P  A  G  A  S  L  R  R  K  G  L  H  S  C  H  I  P  G  C  G  K  V  Y  G  K  T  S  H 
1171 ctcaaggcgcacctgcgctggcacacgggcgagcggcccttcgtgtgcaactggcttttctgcggcaagcgcttcacgcgctccgacgag 
    L  K  A  H  L  R  W  H  T  G  E  R  P  F  V  C  N  W  L  F  C  G  K  R  F  T  R  S  D  E 
1261 ctgcagcggcacctgcggacccacaccggcgagaagcgcttcgcctgtccagtttgcaacaagcgcttcatgcgcagcgaccacctcagc 
    L  Q  R  H  L  R  T  H  T  G  E  K  R  F  A  C  P  V  C  N  K  R  F  M  R  S  D  H  L  S 
1351 aagcacgtgaagacgcacagtggcggcggcggcggcggcggctcggcgggctcgggcagcggcggcaagaagggcagcgacaccgacagc 
    K  H  V  K  T  H  S  G  G  G  G  G  G  G  S  A  G  S  G  S  G  G  K  K  G  S  D  T  D  S 
1441 gagcacagcgccgcgggcagcccgccctgccactccccagagctgctgcagccccccgagcccgggcaccgcaacggcctagagtgacgc 
    E  H  S  A  A  G  S  P  P  C  H  S  P  E  L  L  Q  P  P  E  P  G  H  R  N  G  L  E  *BMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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and not, as the name implies, Sp1 nor Sp4 as previously
stated [16]. The red flour beetle, Tribolium castaneum, Sp8
protein [17] has 43% identity and 80% similarity to
human Sp8. However, D-Sp1 differs from the vertebrate
and beetle Sp8 proteins possessing a much longer,
glutamine and histidine-rich carboxy-terminus. The pos-
session of Sp, BTD and zinc-fingers domains in a protein
is characteristic of Sp proteins in general; these domains in
these three Sp8 proteins are very highly conserved. Out-
side these domains, a motif of unknown function is
located towards the amino-terminal with the sequence
GKGFHPWKKS and is unique to Sp8 proteins.
By comparison with other Sp proteins, the Sp8 protein
can be divided up into 5 domains. The amino-terminal
domain A (residues 1–53) is highly conserved in Sp8 pro-
teins from other species. Two alpha-helices, residues 3–7
and 15–27, are predicted in this domain; whereas the rest
of the protein appears to lack any secondary structure
except for the zinc-finger domain. Domain A is also found
in the Sp7 proteins. Domain B, residues 54–167, is a low-
complexity region, having poly- serine, alanine and gly-
cine stretches that are not present in fish Sp8 proteins.
Domain C, residues 168–373, is similar to the same
region of Sp7 and Sp6 that has been shown to be involved
in transcriptional activation [7] and contains a basic
region (residues 360–371) that probably contributes to a
nuclear localization signal and a BTD-box, a highly con-
served region that is present in all Sp family members. The
BTD-box was first described as a 10-amino-acid region in
the Drosophila zygotic gene, buttonhead [11]. Domain D,
residues 374–456 contains three classical zinc finger struc-
tures (residues 374–456) of the Cys2-His2 type where the
conserved cysteine residues in two short beta-sheets and
the histidine residues in an alpha-helix tetrahedrally co-
ordinate a zinc ion [18]. Between the fingers are five-resi-
due linker sequences with the consensus sequence TGE+x.
The negatively charged carboxy-terminal domain E, resi-
dues 457–508, contains a glycine-rich region (458–475).
Tissue distribution of Sp8 mRNA
The expression of Sp8 in human and murine adult tissues
was examined by reverse transcriptase PCR using primers
located in the 3'UTR. Human Sp8 mRNA expression was
detected in a wide range of tissues at a low level, being
found in heart, brain, placenta, liver, pancreas, prostate,
testis, ovary and colon, but was below the limit of detec-
tion in lung, skeletal muscle, kidney, spleen, thymus,
small intestine and peripheral blood leukocytes (Fig. 5A).
Murine Sp8 mRNA expression, relative to the expression
Gene structure of human Sp8 Figure 2
Gene structure of human Sp8. The human genomic sequences corresponding to the Sp8 cDNAs are located on clones CTA-
324D18 and CTB-86D3. The location of a CpG island is shown in green. The first exon encoding the start of the Sp8L tran-
script is labelled 1a and that of Sp8S, 1b. The ORF is indicated by closed boxes. The sequences around the initiation methionine 
codons (underlined) are shown with those nucleotides corresponding to Kozak consensus sequence coloured red. The loca-
tion of the TGA stop codon and a potential polyadenylation signal, AATAAA are also shown. The sizes of the exons and 
introns, in base pairs, are indicated.
Exon      1a     1b                  2
size     88/21 97           1523/2149 bp
Intron        733  152
1kb
AATAAA GTGATGG GCCATGCT G A
CpG island 438 bpBMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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Sequence comparison of the human Sp8 protein with those from other vertebrate species Figure 3
Sequence comparison of the human Sp8 protein with those from other vertebrate species. The species are man, Homo sapiens, 
Hs; mouse, Mus musculus, Mm; chimpanzee, Pan troglodytes, Pt; rat Rattus norvegicus, Rn and Zebrafish, Danio rerio, Dr. The loca-
tion of the exon/exon boundaries are underlined in black on the protein sequences. The methionine residues at the start of 
translation of Sp8S are underlined in red. The positions of the Sp, BTD-box and three zinc-finger domains found in most Sp 
protein family members are indicated. The conserved residues are shown by (*), strongly conserved residues by (:) and weakly 
conserved residues by (.). Stop codons are indicated by a hash. Residues are colour coded: basic, DE, blue; acidic,_KR, pink; 
polar, CGHNQSTY, green and hydrophobic, AFILMPVW, red.
                      <  Sp box   > 
HsSp8   MATSLLGEEPRLGSTPLAMLAATCNKIGSPSPSPSSLSDSSSSFGKGFHPWKRSSSSSSA  60
PtSp8   MATSLLGEEPRLGSTPLAMLAATCNKIGSPSPSPSSLSDSSSSFGKGFHPWKRSSSSSSA  60
RnSp8   MATSLLGEEPRLGSTPLAMLAATCNKIGSPSPSPSSLSDSSSSFSKGFHPWKRSSSSSSG  60
MmSp8   MATSLLGEEPRLGSTPLAMLAATCNKIGSPSPSPSSLSDSSSSFGKGFHPWKRSSSSSSG  60
DrSp8   MATSLLGEEPRLGSTPLAMLAATCNKIGSPSPSPSSISDNSSSFGKGFHPWKRATASSCS  60
        ************************************:**.****.********:::**.. 
HsSp8   SCNVVGSSLSSFGVSGASRNGGSSSAAAAAAAAAAAAAALVSDSFSCGGSPGSSAFSLTS 120
PtSp8   SCNVVGSSLSSFGVSGASRNGSSSSAAAAAAAAAAAAAALVSDSFSCGGSPGSSAFSLTS 120
RnSp8   SCNVVGSSLSSFGVSGASRNGGSSSAAAAAAAAAAAAAALVSDSFSCGGSPGSSAFSLTS 120
MmSp8   SCNVVGSSLSSFGVSGASRNGGSSSAAAAAAAAAAAAAALVSDSFSCGGSPGSSAFSLTS 120
DrSp8   ----LGSSLSSF-----TRNGGG-----------------LSDSFGTNTSTGSSAFSLTS  94
            :*******     :***..                 :****. . *.********* 
HsSp8   SSAAAAAAAAAAAASSSPFANDYSVFQAPGVSGGSGGGGGGGGGGSSAHSQDGSHQPVFI 180
PtSp8   SSAAAAAAAAAAAASSSPFANDYSVFQAPGVSGGSGGGGGGGGGGSSAHSQDGSHQPVFI 180
RnSp8   SSAAAAAAAAAAAASSSPFANDYSVFQAPGVSGGSGGGGGGGGGGSGAHSQDSSHQPVFI 180
MmSp8   SSAAAAAAAAAAAASSSPFANDYSVFQAPGVSGGSGGGGGGGGGGSGAHSQDSSHQPVFI 180
DrSp8   GT-----------SSNSHFGNDYSVFQT-SVSN---------------NSQEPSHQPMFI 127
        .:            *.* *.*******: .**.               :**: ****:** 
HsSp8   SKVHTSVDGLQGIYPRVGMAHPYESWFKPSHPGLGAAGEVGSAGASSWWDVGAGWIDVQN 240
PtSp8   SKVHTSVDGLQGIYPRVGMAHPYESWFKPSHPGLGAAGEVGSAGASSWWDVGAGWIDVQN 240
RnSp8   SKVHTSVDGLQGIYPRVGMAHPYESWFKPSHPGLGAAADVGSAGASSWWDVGAGWIDVQN 240
MmSp8   SKVHTSVDGLQGIYPRVGMAHPYESWFKPSHPGLGAAADVGSAGASSWWDVGAGWIDVQN 240
DrSp8   SKVHTSVDSLQSIYPRMSVAHPYESWFKSSHPGI-PTGDVGTTGASAWWDVGAGWIDVQN 186
        ********.**.****:.:*********.****: .:.:**::***:************* 
HsSp8   PNSAAALPGSLHPAAGGLQTSLHSPLGGYNSDYSGLSHSAFSSGASSHLLSPAGQHLMDG 300
PtSp8   PNSAAALPGSLHPAAGGLQTSLHSPLGGYNSDYSGLSHSAFSSGASSHLLSPAGQHLMDG 300
RnSp8   PNGAAALPGSLHPAAGGLQTSLHSPLGGYNSDYSGLSHSAFSSGASSHLLSPAGQHLMDG 300
MmSp8   PNGAAALPGSLHPAAGGLQTSLHSPLGGYNSDYSGLSHSAFSSGASSHLLSPAGQHLMDG 300
DrSp8   PNG-AALQTSLH--SGGLQTSLHSPLGGYNSDYSSLSHSAFSTSASPHLLT-TGQHLMDG 242
        *** ***  ***  :*******************.*******:.**.***: :******* 
                                                         BTD-box 
HsSp8   FKPVLPGSYPDSAPSPLAGAGGSMLSAGPSAPLGGSPRSSARRYSGRATCDCPNCQEAER 360
PtSp8   FKPVLPGSYPDSAPSPLAGAGGSMLSAGPSAPLGGSPRSSARRYSGRATCDCPNCQEAER 360
RnSp8   FKPVLPGSYPDSAPSPLAGAGSSMLSAGPAAPLGGSPRSSARRYSGRATCDCPNCQEAER 360
MmSp8   FKPVLPGSYPDSAPSPLAGAGSSMLSAGPAAQLGGSPRSSARRYSGRATCDCPNCQEAER 360
DrSp8   FKPVL-SSYPDSSPSPLGGAGGSMLTGGPTASLAGSPRSSARRYSGRATCDCPNCQEAER 301
        ***** .*****:****.***.***:.**:* *.************************** 
                     <     Zinc-finger 1     >     <   Zinc-finger 2 
HsSp8   LGPAGASLRRKGLHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDE 420
PtSp8   LGPAGASLRRKGLHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDE 420
RnSp8   LGPAGASLRRKGLHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDE 420
MmSp8   LGPAGASLRRKGLHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDE 420
DrSp8   LGPAGASLRRKGLHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDE 361
        ************************************************************ 
        ZNF-2  >     <    Zinc-finger 3    > 
HsSp8   LQRHLRTHTGEKRFACPVCNKRFMRSDHLSKHVKTHSGGGGGGGSAGSG-SGGKKGSDTD 479
PtSp8   LQRHLRTHTGEKRFACPVCNKRFMRSDHLSKHVKTHSGGGGGG-SAGSG-SGGKKGSDTD 478
RnSp8   LQRHLRTHTGEKRFACPVCNKRFMRSDHLSKHVKTHSGGGG---SAGSG--GGKKGSDTD 475
MmSp8   LQRHLRTHTGEKRFACPVCNKRFMRSDHLSKHVKTHSGGGG---SAGSG--GGKKGSDTD 475
DrSp8   LQRHLRTHTGEKRFACPVCNKRFMRSDHLSKHVKTHSAGGSSG-S-GSGASGGKRGSDTD 419
        ************************************* **.   * ***  ***:***** 
HsSp8   SEHSAAGSPPCHSPELLQPPEPGHRNGLE#         508 
PtSp8   SEHSAAGSPPCHSPELLQPPEPGHRNGLE#         507 
RnSp8   SEHSAAGSPPCHSPELLQPPEPGHRNGLE#         504 
MmSp8   SEHSAAGSPPCHSPELLQPPEPGHRNGLE#         504 
DrSp8   SEHSVPGSPSCHSPDLLQAPESVPTTGMNGRASSLD#  455 
        ****..***.****:***.**.   .*:: BMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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Sequence comparison of the human Sp8 protein with those from other invertebrate species; red flour beetle, Tribolium  castaneum, TcSp8 and fruit fly, Drosophila melanogaster Sp8, DmD-Sp1 proteins Figure 4
Sequence comparison of the human Sp8 protein with those from other invertebrate species; red flour beetle, Tribolium casta-
neum, TcSp8 and fruit fly, Drosophila melanogaster Sp8, DmD-Sp1 proteins. The locations of the exon/exon boundaries are 
underlined in black on the protein sequences (GE and S). The methionine residues at the start of translation for the short pro-
tein isoforms are underlined in red (M). The positions of the Sp, BTD-box and three zinc-fingers motifs are shown. Stop 
codons are indicated by a hash.
                                           <  Sp box   > 
HsSp8    MATSLL--------------------GEEPRLGSTPLAMLAATCNKIGSPSPSPSSLSDS 40 
DmDSp1   MLLILKYNP-------FPSF------QDHPSLRGTPLAMLAAQCNKLSNKSPPP--LAD- 44 
TcSp8    MLTDMTPTAGQLYGAQIPAMSMNVKAAEHPSLRGTPLAMLAAQCNKLSNKSPPP--LAD- 57 
         *   :                      : * * .******** ***:.. **.*  *:*  
HsSp8    SSSFGKGFHPWKRSSSSSSASCNVVGSSLSSFGVSGASRNGGSSSAAAAAAAAAAAAAAL 100
DmDSp1   -AAVGKGFHPWKKSPNSPAAGSSGSSGGGGGGGGSSAGQHSPCAISAASSSSSSGSSGGQ 103
TcSp8    -AAVGKGFHPWKKSPQGAPSPSS-----------------TPSSLPTQRTSTSNPTYS-- 97 
          ::.********:*.....: ..                   .: .:  ::::  : .   
HsSp8    VSDSFSCGGSPGSSAFSLTSSSAAAAAAAAAAAASSSPFANDYSVFQAPGVSGGSGGGGG 160
DmDSp1   SSRSLSSSASTMVNITASRPLASSCAAVGGGSTGSSSSASGSQSSSTASAVAAAYGGDLY 163
TcSp8    -----------------SRSVMTSCSSVP---------------------TTASYGSDLY 119
                            .  ::.::.                      .:.. *..   
HsSp8    GGGGGSSAHSQD---GSHQPVFISKVHTSVDGLQG-IYPRVGMAHPYESWFKPSHPGLGA 216
DmDSp1   FP-NTSTSNMDN---HHMHQGLLGKVEAGAAAFGG-VYSR----HPYD-WPFN---AVTH 210
TcSp8    FPGATSQPPTDNSHVHHHQTSLLGKVEGAATHHLGSVYSR----HPYESWPFNTMSGATH 175
           .  * .  ::      :  ::.**. ..    * :*.*    ***: *      .    
HsSp8    AG--EVGSAGASSWWDVGAGWIDVQNPNSAAALPGSLHPAAGGLQTSLHSPLGGYNSDYS 274
DmDSp1   K---EAASVNS-GWWDMHS--------------AAGSWLDMGG--AGMHS----TMANYA 246
TcSp8    HGGIKSDSVTSNAWWDVHS--------------TG-SWLDMSGGMHQMAN----YSTDYS 216
             :  *. : .***: :                      .*    : .. ..  ::*: 
HsSp8   GLSHSAFSSGASSHLLSPAGQHLM-DGFKPVLPGSYP----------------------DS 312
DmDSp1  SENY---SSALSHSLLGS-GQHLLQDTYKSMLPGQGVGVGVGVGMGGFSLPHSSPSAAAAA 303
TcSp8   SLTH---SLAASNHLLSS-GQHLLQDTYKSMLPGAQT---VGASFG---------LHATGS 261
        . .:   * . *  **...****  * :*.:***                          : 
                                              BTD-box 
HsSp8    APSPLAGAGGSMLSAGPSAPLGGSPRSSARRYSGRATCDCPNCQEAERLGPAGASLRRKG 372
DmDSp1   AATAAAAAGGSPQGGSPSTPS---PRS-QRRYAGRATCDCPNCQEAERLGPAGVHLRKKN 359
TcSp8    APSPTAGAGGLP----PQVPS---PRS-QRRYTGRATCDCPNCQEAERLGPAGVHLRKKN 313
         *.:. *.***   ...*..* ..:***: ***:********************. **:*. 
          <     Zinc-finger 1     >     <     Zinc-finger 2     > 
HsSp8    LHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDELQRHLRTHTGEK 432
DmDSp1   IHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDELQRHLRTHTGEK 419
TcSp8    IHSCHIPGCGKVYGKTSHLKAHLRWHTGERPFVCNWLFCGKRFTRSDELQRHLRTHTGEK 373
         :*********************************************************** 
          <    Zinc-finger 2    > 
HsSp8    RFACPVCNKRFMRSDHLSKHVKTHSGGGGGGGSAGSGSGGKKGSDTDSEHSAAGSPPCHS 492
DmDSp1   RFACPVCNKRFMRSDHLAKHVKTHNGTANHQAN-GHNGGLKKGSSESCSDSEEAANQSGE 478
TcSp8    RFACPICNKRFMRSDHLAKHVKTHNGNG------------KKGSSDSCSDSEENSQSDIT 421
         *****:***********:******.*              ****      *       
TcSp8    SNNVNSPASMNQTPPPTAQMGLDMVTGLDVKPPGLV# 456 
DmDSp1   NGLGGVGSGPQTGGAGGGGGGSSSGNGAGTLAVSGSVTTGAGAGSGTGSSNSNSNSGGSS 539
HsSp8    PELLQPPEPGHRNGLE# 508 
DmDSp1   GSVSGSVSGSGSHPGTPTSLHAHSANGTSSSLLGGGLHLATPHQMVAAGGSPVMLHQQQQ 599
DmDSp1   QQQHQQQQQQQQQQQHQQQQQQQHQQQQQQHQQQQQQHHQQQQQHHHQQFGQQQHPHAHH 659
DmDSp1   LHHHAHHAHHLATGGSPGLDPSSLVDIKPPMV# 691 BMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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of beta-actin mRNA, was detected in all tissues examined,
with the highest levels being found in brain and prostate
and the lowest in spleen (Fig. 5B).
Expression of human Sp8 mRNA in osteoblast-like cells
The expression of both transcript variants mRNAs encod-
ing Sp8L and Sp8S in osteoblast-like cells was examined
by reverse transcriptase PCR using primers specific for
each isoform (Fig. 6). The Sp8L was most abundant in the
osteosarcoma cell lines HOS and MG63 and was present
in adult and craniofacial osteoblasts, but was below the
limit of detection in foetal osteoblasts and chondrocytes.
The Sp8S was most abundant also in the osteosarcoma
cell lines HOS and MG63 and was present in craniofacial
and foetal osteoblasts, but was below the limit of detec-
tion in adult osteoblasts and chondrocytes. Runx2, a tran-
scription factor important for osteoblast differentiation,
and beta-actin, a housekeeping gene, were expressed in all
the osteoblast-like cells.
BMP-2 regulation of Sp8 mRNA expression in the murine 
cell line in C3H10T1/2
BMPs are potent secreted factors that promote osteoblast
differentiation during development and bone
Expression of Sp8 mRNA in human and mouse adult tissues determined by RT-PCR using primers located in the 3'UTR Figure 5
Expression of Sp8 mRNA in human and mouse adult tissues determined by RT-PCR using primers located in the 3'UTR. A. 
Ethidium bromide stained agarose gel of PCR products from human tissues. The lanes are: skeletal muscle, muscle; small intes-
tine, intestine; peripheral blood leukocytes, leukocyte; negative control, -c and 100 bp ladder, m. The expression of beta-actin 
mRNA, a housekeeping gene, in the same samples is shown below. B. RT real time PCR of murine Sp8 mRNA expression nor-
malised to that of beta-actin.
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remodelling. Since Sp8 was found in human osteosar-
coma cell lines and is important in skeletal development
[9,10] we examined the regulation of Sp8 by BMP-2 in the
murine pluripotent embryonic cell line, C3H10T1/2 that
Expression of Sp8 mRNAs in human osteoblast-like cells by reverse transcriptase PCR Figure 6
Expression of Sp8 mRNAs in human osteoblast-like cells by reverse transcriptase PCR. Amplicons were run on an ethidium 
bromide stained agarose gel. The amplicons were: Sp8 long protein isoform, Sp8L; Sp8 short protein isoform, Sp8S; Runx2/
Cbfa1, Runx2 and the housekeeping gene beta-actin. The sizes of the amplicons are indicated. The lanes are: primary adult 
osteoblasts, AO; HOS osteosarcoma cell line, HS; MG63 osteosarcoma cell line, MG; primary craniofacial osteoblasts, CF; pri-
mary foetal osteoblasts, FO; primary adult chondrocytes, CH; negative control, (-) and 100 bp markers, m.
Time course of effect of 100 ng/mL BMP-2 treatment on C3H10T1/2 cells Figure 7
Time course of effect of 100 ng/mL BMP-2 treatment on C3H10T1/2 cells. Murine Sp8 and beta-actin mRNA expression was 
determined by RT real time PCR. The relative levels of expression in treated (•) and untreated cells (◆ ) were examined after 
0, 7, 14 and 20 days treatment. Significant increases in Sp8 expression were seen at 7, 14 and 20 days (p < 0.05).
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can be induced to form a chondrogenic/osteoblastic phe-
notype by treatment with BMPs [19-21]. Sp8 mRNA
expression, normalised to that of beta-actin, was meas-
ured by RT-real time PCR and was induced by 100 ng/mL
BMP-2 after one day and remained upregulated at 20 days
(Fig. 7). Data normalised to the housekeeping gene
G3PDH gave similar results (data not shown) indicating
that Sp8 was upregulated and that beta-actin was not
down-regulated.
Discussion
In the human genome three Sp gene pairs had been
described previously; being maximally separated by 3.2
Mbp, transcribed in opposite directions, being orientated
5' to 5' manner and colocalized with a specific HOX gene
clusters [8]. Sp3 and Sp5 are located on chromosome
2q31.1; Sp1 and Sp7 on 12q13.13 and Sp2-Sp6 on
17q21.3-q22. A search for a partner to Sp4 located on
7q21.3-q22 revealed a putative eighth Sp gene most simi-
lar to Sp7 suggesting that Sp8, like Sp7, may play a role
also in skeletal development. Consequently, we used RT-
PCR to amplify Sp8 cDNAs from a human osteosarcoma
cell line and isolated two transcript variants clones that
encode a full-length protein (long isoform) Sp8L and an
amino-terminal truncated protein (short isoform) Sp8S,
with 508 and 490 residues respectively. We found a gly-
cine-165 deletion mutation in an additional cDNA clone
isolated from a patient with osteoporosis. The length of
this poly-glycine region is conserved in primates and
rodents, but is absent in fish. We speculate that this Sp8
mutation, and other mutations yet to be discovered, may
play a role in susceptibility to osteoporosis, and since Sp8
plays an important role in neuropore closure be a candi-
date gene for spina bifida [9].
The sequence of our Sp8L clone is similar to that of two
other human clones, but the other two clones lack 170
and 128 bp of the low-complexity, B domain (GenBank
accession Nos. BAB71297 and AAH38669). These dele-
tions may be caused by incomplete reverse transcriptase
reactions occurring during cDNA library synthesis, pre-
sumably because the high GC content (81%) generates
strong secondary structure in the mRNA in this region.
These deletion-carrying clones are unlikely to be gener-
ated by the presence of cryptic intron(s) since no suitable
donor or acceptor splice sites are present in the genomic
DNA sequence. One of the deletion-carrying clones,
AAH38669, possesses a polymorphism, cac>cgc, at
nucleotide 1263 that results in a His>Arg mutation at res-
idue 448. His-448 is located in the third zinc- finger and
is conserved in all Sp proteins and, by homology with
Sp1, is likely to contact DNA [18]. This mutated protein
would be expected to be deleterious, having reduced affin-
ity for GC-box binding sites in promoter regions.
We found that in man Sp8 has two transcript variants uti-
lising two different first exons. Sequence analyses of
mouse and zebrafish genomic and EST data support this
gene structure for Sp8 in vertebrates and not a gene
structure with two untranslated 5' exons that has been
suggested for murine Sp8 [10]. Interestingly, the dro-
sophila D-Sp1 gene, a Sp8 homologue, also has two tran-
script variants, encoding long and short protein isoforms
(accession No. AE003448) [22]. Both Sp8 and Sp7 have a
similar exon structure, being three-exon genes with two
transcript variants with different first exons [8]. The long
protein isoforms use translated first exons that encodes
seven residues and the short protein isoforms use untrans-
lated first exons; overall, the proteins have 39.5% identity
and 65.9% similarity. Both the Sp8S and Sp7S proteins
lack an 18-residue amino-terminus thereby disrupting a
hydrophobic region termed the Sp domain that is con-
served in other Sp proteins. The conservation of the two
protein isoforms through evolution suggests that they
have differing roles. Although the function of this hydro-
phobic region is unknown, other zinc-finger transcription
proteins often have a conserved protein-protein interac-
tion domain at their amino-terminus (e.g. BTB or kelch
domains). This indicates that the Sp motif may also be
involved in a protein-protein interaction and that the
short protein isoforms do not have this protein interac-
tion domain.
Amino-terminal spliced variants expressed from separate
promoters are a feature of other important transcription
factors that regulate skeletal development. An oestrogen
regulated protein in osteoblasts, KLF10 is another mem-
ber of the Sp/Krüppel-like factor family that has two
amino-terminal variant isoforms generated in a similar
way to those of Sp8. These isoforms are named the TGFβ-
inducible early gene (TIEG1) and the early growth
response gene-alpha [23-25]. Runx2 has two major
amino-terminal isoforms that exert different functions
during the process of osteoblast differentiation; the
Runx2-type-I isoform is widely expressed in
osteoprogenitor cells and active osteoblasts, whereas the
Runx2-type-II isoform is restricted to cells lining
mineralised bones [26] and BMP-2 preferentially upregu-
lates the Runx2-type-II isoform [27].
Sp8 does not initiate BMP-mediated signalling during api-
cal ectodermal ridge formation, but may function down-
stream of the BMP receptor-1a in the signalling cascade
[9,10]. The signalling events downstream of the BMP
receptor that result in tissue-specific gene expression and
skeletal development have been only partially elucidated.
We found that Sp8 expression was induced by 100 ng/mL
BMP-2 only after 24 hours in C3H10T1/2 cells. BMP-2 has
been shown to induce several other transcription factors
that promote differentiation such as Runx2/Cbfa1, Sp7/BMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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osterix and ZNF450 in addition to the negative regulator
Id1 [7,28-30]. Induction of these genes in C3H10T1/2
cells occurs within 4 hours, preceding that of Sp8, suggest-
ing that Sp8 is not directly regulated by BMP signalling
and that it may be induced by one or more of the BMP-
early-induced genes.
The Sp8 gene has a wider phylogenetic distribution than
Sp7, being found in coelomates, whereas Sp7 is limited to
vertebrates. In view of the close similarities between
human Sp8 and Sp7 in gene structure and amino acid
sequence we speculate that they evolved from an ancestral
Sp8 gene during a duplication of a Sp/Hox gene cluster
[31]. The Sp8 gene has retained its function in regulating
appendage/limb growth [9,10,12,17] and that Sp7 has
subsequently evolved a novel function, namely, regulat-
ing cartilage/bone formation [7].
Conclusions
In humans, there are two transcript variants of Sp8 that
utilise different first exons encoding long and short pro-
tein isoforms. These two isoforms are conserved being
found also in the zebrafish suggesting that they have dis-
tinct functions. Sp8 is upregulated by BMP-2 in the
murine pluripotent cell line C3H10T1/2 and may play a
role in mesenchymal differentiation.
Methods
Cell culture and RNA extraction
Two cell lines derived from osteosarcomas, HOS and MG-
63, were cultured at 37°C in 5% CO2 using Dulbecco's
Modified Eagle's Medium, containing 4 mM L-glutamine,
4500 mg glucose/L, 1500mg bicarbonate/L (Invitrogen,
UK) with the addition of 10% foetal bovine serum, 10 µM
ascorbic acid, 100 IU/mL penicillin and 50 µg/ml strepto-
mycin. Primary human osteoblasts were isolated from
trabecular bone of femoral heads taken during total hip
arthroplasty and cultured as previously described [32].
Primary human craniofacial osteoblasts were obtained
from paediatric skull and cultured as previously described
[33]. Human primary foetal osteoblasts were obtained
and cultured as previously described [34]. Human pri-
mary articular chondrocytes were obtained from isolated
femoral heads and cultured as previously described [35].
The murine cell line C3H10T1/2 was cultured in Dul-
becco's modified Eagle's medium supplemented with 50
U/mL penicillin, 50 µg/mL streptomycin (Invitrogen) and
10% new born bovine serum (Sigma) at 37°C under 5%
CO2 in a humidified incubator. Prior to BMP-2 treatment,
cells were seeded at a density of approximately 40,000
cells/cm2, left for 24 hours, then treated with fresh media
with or without 100 ng/mL human recombinant BMP-2
(Wyeth Corporation) and the media replaced every three
days.
Total RNA was extracted from cells using guanidine thio-
cyanate and treated with DNase-I to remove any contam-
inating genomic DNA (SV Total RNA isolation system,
Promega, UK). The concentration and purity of eluted
RNA was determined spectrophotometrically and the
quality of the RNA was verified by non-denaturating
agarose gel electrophoresis. For Sp8 cloning, total RNA
was reverse transcribed with an oligo-dT primer using
ThermoScript, an AMV RNase H- reverse transcriptase at
an elevated temperature of 60°C (Invitrogen, UK).
Molecular cloning of human Sp8
The human Sp7 protein sequence [8] was used to search
the human genome sequence and the EST database to
identify closely related genes. PCR primers designed from
the sequence of genomic DNA clones CTA-324D18, CTB-
86D3 and EST sequence from Image clone 2721342
(accession No. AW207154) were used to clone two tran-
script variants spliced isoforms of the human Sp8 cDNA
by PCR from MG-63 osteosarcoma cell line cDNA. The
PCR primers were: Sp8L forward, ATTGTATTGCACAC-
CTCTAAAAAAAACA; Sp8S forward, GCGTGGTGCTT-
GCTCCC and common reverse,
GCGTCACTCTAGGCCGTTG (Helena Biosciences,
France). The cDNAs were amplified by PCR with an
annealing temperature of 60°C using the Advantage-GC
Advantage kit (Clontech, UK) with the addition of 0.5 M
GC-Melt since the DNA sequence of Sp8 is GC-rich. PCR
products were excised from agarose gels stained with
ethidium bromide and eluted from the agarose using a
DNA extraction kit (Qiagen, UK). The PCR products were
cloned into the T-A vector pCR4-TOPO (Invitrogen, The
Netherlands). Transformed colonies were picked and vec-
tors containing inserts were extracted using the Wizard
Plus SV minipreps DNA purification system (Promega,
UK) and sequenced in both directions using ThermoFide-
lase 2 (Fidelity Systems Inc., USA).
Tissue and cellular distribution of human Sp8 mRNA by 
reverse transcriptase PCR
Human cDNA was analysed for the relative expression of
the Sp8, Runx2/Cbfa1 and beta-actin mRNA by PCR. Six-
teen adult tissue cDNAs (BD Clontech, UK) were gener-
ated from polyA+ selected RNA and reverse transcribed
using an oligo-dT primer. Total RNA from cell type cDNAs
were reversed transcribed using random hexamer primers
using an AMV RNase H- reverse transcriptase (Thermo-
Script, Invitrogen, UK) at 60°C. Approximately 4.0 ng of
cDNA from each tissue, and cDNA derived from 50 ng of
total RNA from each cell type were amplified by PCR
using Taq Gold polymerase. Tissue master mixes were
divided into gene specific mixes with the addition of PCR
primers to a final concentration of 200 µM. The primers
were: Sp8L forward primer, GCAACTTCACTTCTAG-
GGGAAGA(exon 1a/2); Sp8S forward primer,BMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
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TGGGGGTGCCAGGAAGAAC(exon 1b/2) and a com-
mon reverse primer, AGCTGTCCGAGAGGGAGGA (exon
2), producing a 118 and 112 bp amplicons respectively;
Sp8 3'UTR, TTAGTCCGGCCGTCAATTGT and TGGTATT-
TAAACTACAGCCTCGTCTGA, producing a 151 bp ampli-
con; Runx2, AGAAGAGCCAGGCAGGTGCT(exon 6/7)
and TTCGTGGGTTGGAGAAGCG (exon 7), producing a
102 bp amplicon, as measure of the sum of all Runx2 iso-
forms, and beta-actin, GGCCACGGCTGCTTC and GTT-
GGCGTACAGGTCTTTGC, producing a 208 bp amplicon.
The amplification conditions were; a 10 min hot start to
activate the polymerase followed by 50 cycles of 95°C for
15 sec and 60°C for 1 min. Amplification specificity was
confirmed by direct sequencing of the amplicons.
Expression of murine Sp8 mRNA by real time PCR
Utilising a CAS-1200 robotic precision liquid handling
system, PCR was carried out on a Rotor Gene 3000 (Cor-
bett Research, Australia) using a SYBR Green I double-
stranded DNA binding dye assay. Copy DNA derived from
200 ng of total RNA from each sample was amplified by
PCR using Taq Gold polymerase using PCR primers to a
final concentration of 50 nM. The primers were: mouse
Sp8 3'UTR, CCATTCAGCTCTGGCTAGGTCTT and GAT-
TCCCGTTCGCAGAACTC producing a 67 bp amplicon.
Beta-actin mRNA was used as a control gene as previously
described [36]. The amplification conditions were; a 10
min hot start to activate the polymerase followed by 40
cycles of 95°C for 15 sec and 60°C for 1 min. The number
of cycles required for the fluorescence to become signifi-
cantly higher than background fluorescence (termed cycle
threshold [Ct]) was used as a measure of abundance. A
comparative Ct  method was used to determine gene
expression. Expression levels in each cDNA sample were
normalised to the expression levels of the control gene
(∆Ct). The ratios of Sp8 mRNA/control gene RNA from
each cDNA were standardised to that of the untreated cells
on day 0 that was taken as 100% (∆∆Ct). The formula E-
∆∆Ct was used to calculate relative expression levels where
E is the efficiency of the PCR per cycle. Statistically signif-
icant changes in gene expression were determined using
the t-test on data from three replicate experiments. The
amplification specificity was confirmed by melting curve
analysis and agarose gel electrophoresis.
Authors' contributions
AJE conceived of the study, and participated in its design
and coordination. MAM, JEG and AJE carried out the cell
culture work, MAM and AJE carried out the expression
studies and MAM and AJE carried out the gene cloning. All
authors participated in writing the manuscript, read, and
approved the final manuscript.
Acknowledgements
We thank the Advanced Biotechnology Centre for DNA sequencing (Char-
ing Cross Campus, Imperial College, London), Drs Bruce C. Knight, Chris 
Murphy and Colin Scotchford for providing primary foetal osteoblasts, 
adult chondrocytes and the osteosarcomas cell lines and June Edgar for crit-
ically reading the manuscript.
References
1. Dynan WS, Tjian R: Isolation of transcription factors that dis-
criminate between different promoters recognized by RNA
polymerase II. Cell 1983, 32:669-680.
2. Yoo J, Jeong MJ, Kwon BM, Hur MW, Park YM, Han MY: Activation
of dynamin I gene expression by Sp1 and Sp3 is required for
neuronal differentiation of N1E-115 cells.  J Biol Chem 2002,
277:11904-11909.
3. Kolell KJ, Crawford DL: Evolution of Sp transcription factors.
Mol Biol Evol 2002, 19:216-222.
4. Yu B, Datta PK, Bagchi S: Stability of the Sp3-DNA complex is
promoter-specific: Sp3 efficiently competes with Sp1 for
binding to promoters containing multiple Sp-sites.  Nucleic
Acids Res 2003, 31:5368-5376.
5. Chadjichristos C, Ghayor C, Kypriotou M, Martin G, Renard E, Ala-
Kokko L, Suske G, de Crombrugghe B, Pujol JP, Galera P: Sp1 and
Sp3 transcription factors mediate interleukin-1 beta down-
regulation of human type II collagen gene expression in
articular chondrocytes. J Biol Chem 2003, 278:39762-39772.
6. Gollner H, Dani C, Phillips B, Philipsen S, Suske G: Impaired ossifi-
cation in mice lacking the transcription factor Sp3. Mech Dev
2001, 106:77-83.
7. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR,
de Crombrugghe B: The novel zinc finger-containing transcrip-
tion factor osterix is required for osteoblast differentiation
and bone formation. Cell 2002, 108:17-29.
8. Milona MA, Gough JE, Edgar AJ: Expression of alternatively
spliced isoforms of human Sp7 in osteoblast-like cells. BMC
Genomics 2003, 4:43.
9. Bell SM, Schreiner CM, Waclaw RR, Campbell K, Potter SS, Scott WJ:
Sp8 is crucial for limb outgrowth and neuropore closure. Proc
Natl Acad Sci U S A 2003, 100:12195-12200.
10. Treichel D, Schock F, Jackle H, Gruss P, Mansouri A: mBtd is
required to maintain signaling during murine limb
development. Genes Dev 2003, 17:2630-2635.
11. Cohen SM, Jurgens G: Mediation of Drosophila head develop-
ment by gap-like segmentation genes.  Nature 1990,
346:482-485.
12. Wimmer EA, Jackle H, Pfeifle C, Cohen SM: A Drosophila homo-
logue of human Sp1 is a head-specific segmentation gene.
Nature 1993, 366:690-694.
13. Kozak M: An analysis of 5'-noncoding sequences from 699 ver-
tebrate messenger RNAs. Nucleic Acids Res 1987, 15:8125-8148.
14. Philipsen S, Suske G: A tale of three fingers: the family of mam-
malian Sp/XKLF transcription factors. Nucleic Acids Res 1999,
27:2991-3000.
15. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S,
Nikaido I, Osato N, Saito R, Suzuki H, Yamanaka I, Kiyosawa H, Yagi
K, Tomaru Y, Hasegawa Y, Nogami A, Schonbach C, Gojobori T,
Baldarelli R, Hill DP, Bult C, Hume DA, Quackenbush J, Schriml LM,
Kanapin A, Matsuda H, Batalov S, Beisel KW, Blake JA, Bradt D, Brusic
V, Chothia C, Corbani LE, Cousins S, Dalla E, Dragani TA, Fletcher
CF, Forrest A, Frazer KS, Gaasterland T, Gariboldi M, Gissi C, Godzik
A, Gough J, Grimmond S, Gustincich S, Hirokawa N, Jackson IJ, Jarvis
ED, Kanai A, Kawaji H, Kawasawa Y, Kedzierski RM, King BL, Kona-
gaya A, Kurochkin IV, Lee Y, Lenhard B, Lyons PA, Maglott DR,
Maltais L, Marchionni L, McKenzie L, Miki H, Nagashima T, Numata K,
Okido T, Pavan WJ, Pertea G, Pesole G, Petrovsky N, Pillai R, Pontius
JU, Qi D, Ramachandran S, Ravasi T, Reed JC, Reed DJ, Reid J, Ring
BZ, Ringwald M, Sandelin A, Schneider C, Semple CA, Setou M, Shi-
mada K, Sultana R, Takenaka Y, Taylor MS, Teasdale RD, Tomita M,
Verardo R, Wagner L, Wahlestedt C, Wang Y, Watanabe Y, Wells C,
Wilming LG, Wynshaw-Boris A, Yanagisawa M, Yang I, Yang L, Yuan
Z, Zavolan M, Zhu Y, Zimmer A, Carninci P, Hayatsu N, Hirozane-
Kishikawa T, Konno H, Nakamura M, Sakazume N, Sato K, Shiraki T,
Waki K, Kawai J, Aizawa K, Arakawa T, Fukuda S, Hara A, Hashizume
W, Imotani K, Ishii Y, Itoh M, Kagawa I, Miyazaki A, Sakai K, Sasaki D,
Shibata K, Shinagawa A, Yasunishi A, Yoshino M, Waterston R, Lander
ES, Rogers J, Birney E, Hayashizaki Y: Analysis of the mouse tran-
scriptome based on functional annotation of 60,770 full-
length cDNAs. Nature 2002, 420:563-573.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2004, 5:86 http://www.biomedcentral.com/1471-2164/5/86
Page 12 of 12
(page number not for citation purposes)
16. Wimmer EA, Frommer G, Purnell BA, Jackle H: buttonhead and D-
Sp1: a novel Drosophila gene pair. Mech Dev 1996, 59:53-62.
17. Beermann A, Aranda M, Schroder R: The Sp8 zinc-finger tran-
scription factor is involved in allometric growth of the limbs
in the beetle Tribolium castaneum.  Development 2004,
131:733-742.
18. Narayan VA, Kriwacki RW, Caradonna JP: Structures of zinc fin-
ger domains from transcription factor Sp1. Insights into
sequence-specific protein-DNA recognition. J Biol Chem 1997,
272:7801-7809.
19. Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LC: BMP treatment
of C3H10T1/2 mesenchymal stem cells induces both chon-
drogenesis and osteogenesis. J Cell Biochem 2003, 90:1112-1127.
20. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V,
Wang EA, Tanaka H, Omura S, Suda T: The non-osteogenic
mouse pluripotent cell line, C3H10T1/2, is induced to differ-
entiate into osteoblastic cells by recombinant human bone
morphogenetic protein-2.  Biochem Biophys Res Commun 1990,
172:295-299.
21. Wang EA, Israel DI, Kelly S, Luxenberg DP: Bone morphogenetic
protein-2 causes commitment and differentiation in
C3H10T1/2 and 3T3 cells. Growth Factors 1993, 9:57-71.
22. Schock F, Purnell BA, Wimmer EA, Jackle H: Common and
diverged functions of the Drosophila gene pair D-Sp1 and
buttonhead. Mech Dev 1999, 89:125-132.
23. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL,
Spelsberg TC: Identification of a novel TGF-beta-regulated
gene encoding a putative zinc finger protein in human
osteoblasts. Nucleic Acids Res 1995, 23:4907-4912.
24. Blok LJ, Kumar MV, Tindall DJ: Isolation of cDNAs that are dif-
ferentially expressed between androgen-dependent and
androgen-independent prostate carcinoma cells using differ-
ential display PCR. Prostate 1995, 26:213-224.
25. Tau KR, Hefferan TE, Waters KM, Robinson JA, Subramaniam M,
Riggs BL, Spelsberg TC: Estrogen regulation of a transforming
growth factor-beta inducible early gene that inhibits deox-
yribonucleic acid synthesis in human osteoblasts. Endocrinology
1998, 139:1346-1353.
26. Choi KY, Lee SW, Park MH, Bae YC, Shin HI, Nam S, Kim YJ, Kim HJ,
Ryoo HM: Spatio-temporal expression patterns of Runx2 iso-
forms in early skeletogenesis. Exp Mol Med 2002, 34:426-433.
27. Banerjee C, Javed A, Choi JY, Green J, Rosen V, van Wijnen AJ, Stein
JL, Lian JB, Stein GS: Differential regulation of the two principal
Runx2/Cbfa1 n-terminal isoforms in response to bone mor-
phogenetic protein-2 during development of the osteoblast
phenotype. Endocrinology 2001, 142:4026-4039.
28. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: a
transcriptional activator of osteoblast differentiation.  Cell
1997, 89:747-754.
29. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A: Id
genes are direct targets of bone morphogenetic protein
induction in embryonic stem cells.  J Biol Chem 1999,
274:19838-19845.
30. Edgar AJ, Dover SL, Lodrick MN, McKay IJ, Hughes FJ, Turner W:
Bone Morphogenetic Protein-2 Induces Expression Of
Murine Zinc Finger Transcription Factor ZNF450.  J Cell
Biochem  in press.
31. Prince V: The Hox Paradox: More complex(es) than
imagined. Dev Biol 2002, 249:1-15.
32. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM: Ionic products
of bioactive glass dissolution increase proliferation of human
osteoblasts and induce insulin-like growth factor II mRNA
expression and protein synthesis. Biochem Biophys Res Commun
2000, 276:461-465.
33. Gough JE, Christian P, Scotchford CA, Rudd CD, Jones IA: Synthe-
sis, degradation, and in vitro cell responses of sodium phos-
phate glasses for craniofacial bone repair. J Biomed Mater Res
2002, 59:481-489.
34. Harris SA, Enger RJ, Riggs BL, Spelsberg TC: Development and
characterization of a conditionally immortalized human
fetal osteoblastic cell line. J Bone Miner Res 1995, 10:178-186.
35. Murphy CL, Sambanis A: Effect of oxygen tension and alginate
encapsulation on restoration of the differentiated phenotype
of passaged chondrocytes. Tissue Eng 2001, 7:791-803.
36. Edgar AJ, Polak JM: Cloning and tissue distribution of three
murine alpha/beta hydrolase fold protein cDNAs. Biochem Bio-
phys Res Commun 2002, 292:617-625.